http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19356004

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Research Support, Non-U.S. Gov't
endingPage 959
issn 1476-5381
0007-1188
issueIdentifier 8
pageRange 952-959
publicationName British Journal of Pharmacology
startingPage 952
bibliographicCitation MacInnes N, Duty S. Locomotor effects of imidazoline I2‐site‐specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6‐hydroxydopamine lesion of the nigrostriatal pathway. British J Pharmacology. 2004 Dec;143(8):952–9. doi: 10.1038/sj.bjp.0706019.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_518a5eb7f3b3dd1a12fdb825283a9cbd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e975a1276083b61eaad400d5fba50c19
date 200412
identifier https://pubmed.ncbi.nlm.nih.gov/PMC1575965
https://pubmed.ncbi.nlm.nih.gov/15545290
https://doi.org/10.1038/sj.bjp.0706019
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895
https://portal.issn.org/resource/ISSN/0007-1188
https://portal.issn.org/resource/ISSN/1476-5381
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Locomotor effects of imidazoline I2‐site‐specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6‐hydroxydopamine lesion of the nigrostriatal pathway
discusses http://id.nlm.nih.gov/mesh/M0018572
http://id.nlm.nih.gov/mesh/M0275927
http://id.nlm.nih.gov/mesh/M0025343
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0469121
http://id.nlm.nih.gov/mesh/M0014029
http://id.nlm.nih.gov/mesh/M0159970
http://id.nlm.nih.gov/mesh/M0012508
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011955Q000502
http://id.nlm.nih.gov/mesh/D003342Q000187
http://id.nlm.nih.gov/mesh/D009043Q000187
http://id.nlm.nih.gov/mesh/D013378Q000187
http://id.nlm.nih.gov/mesh/D008996Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D009434Q000201
http://id.nlm.nih.gov/mesh/D003342Q000502
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D054755
http://id.nlm.nih.gov/mesh/D009043Q000502
http://id.nlm.nih.gov/mesh/D008024
http://id.nlm.nih.gov/mesh/D013378Q000201
http://id.nlm.nih.gov/mesh/D009434Q000502
http://id.nlm.nih.gov/mesh/D009434Q000187
http://id.nlm.nih.gov/mesh/D013378Q000502
http://id.nlm.nih.gov/mesh/D007093Q000494
http://id.nlm.nih.gov/mesh/D017207
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D016627
http://id.nlm.nih.gov/mesh/D003342Q000201
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3080926
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4235
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.4.3.4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68156

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID92729659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128645717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135758458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129798217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID57309677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127741037

Total number of triples: 73.